Specimens and Genetic Data Sample Clauses

Specimens and Genetic Data. Any and all biological materials and samples, such as blood or tissue, from a Trial Participant collected pursuant to the Protocol (“Specimens”) as well as RNA, DNA, and protein sequence, restriction fragment length polymorphism (RFLP), and similar data collected pursuant to the Protocol (“Genetic Data”) shall be solely owned by Sponsor. Any use of Genetic Data and/or Specimens, whether such use occurs as part of or outside of the Trial will be in accordance with the Protocol, other written instruction, the informed consent form, and Applicable Law. Sponsor grants Institution access to Specimens and Genetic Data only for purposes of the Trial. Institution and Investigator shall deliver all Specimens and Genetic Data to Sponsor or its respective designee in a timely manner throughout the performance of the Trial, as provided in the Protocol, in no event later than sixty (60) days following the completion of the Trial by Institution and Investigator or the earlier termination of this Agreement.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Specimens and Genetic Data. Sponsor shall have the exclusive right and license to use any and all biological materials and samples, such as blood or tissue, from a Trial Participant collected pursuant to the Protocol (“Specimens”) as well as RNA, DNA, and protein sequence, restriction fragment length polymorphism (RFLP), and similar data collected pursuant to the Protocol (“Genetic Data”). Any use of Genetic Data and/or Specimens, whether such use occurs as part of or outside of the Trial will be in accordance with the Protocol, other written instruction, the informed consent form, and Applicable Law. Sponsor grants Provider access to Specimens and Genetic Data only for purposes of the Trial. Provider and Investigator shall deliver all Specimens and Genetic Data to Sponsor or its respective designee in a timely manner throughout the performance of the Trial, as provided in the Protocol, in no event later than sixty (60) days following the completion of the Trial by Provider and Investigator or the earlier termination of this Agreement.
Sample 1Sample 2
Specimens and Genetic Data. Sponsor shall have the exclusive right and license to use any and all biological materials
Sample 1
Specimens and Genetic Data. Sponsor shall have the exclusive right and license to use any and all biological materials and samples, such as blood or tissue, from a Trial Participant collected pursuant to the Protocol (“Specimens”) as well as RNA, DNA, and protein sequence, restriction fragment length polymorphism (RFLP), and similar data collected pursuant to the Protocol (“Genetic Data”). Any use of Genetic Data and/or Specimens, whether such use occurs as part of or outside of the Trial will be in accordance with the Protocol, other written instruction, the informed consent form, and Applicable Law. Sponsor grants Institution access to Specimens and Genetic Data only for purposes of the Trial. Institution and Investigator shall deliver all Specimens 6.5 Vzorky a genetická data. Zadavatel bude mít výhradní právo a licenci užívat veškeré biologické materiály a vzorky Subjektů hodnocení, například krev nebo tkáně, shromážděné dle Protokolu (dále jen „Vzorky“), jakož i RNA, DNA a proteinové sekvence, polymorfismus délky restrikčních fragmentů (RFLP) a podobné údaje shromážděné dle Protokolu (dále jen „Genetická data“). Veškeré užívání Genetických dat a/nebo Vzorků v rámci nebo mimo rámec Klinické hodnocení musí být vždy v souladu s Protokolem, jinými písemnými pokyny, s formulářem informovaného souhlasu a s Příslušnými právními předpisy. Zadavatel povoluje Zdravotnickému zařízení přístup ke Vzorkům a Genetickým datům pouze and Genetic Data to Sponsor or its respective designee in a timely manner throughout the performance of the Trial, as provided in the Protocol, in no event later than sixty (60) days following the completion of the Trial by Institution and Investigator or the earlier termination of this Agreement. pro účely Klinického hodnocení. Zdravotnické zařízení a Zkoušející budou předávat Zadavateli nebo jím ustanovené osobě všechny Vzorky a Genetická data během celé doby provádění Klinického hodnocení včas, jak je stanoveno v Protokolu, ale v každém případě nejpozději šedesát
Sample 1
Specimens and Genetic Data. Sponsor shall have the exclusive right and license to use any and all biological materials and samples, such as blood or tissue, from a Trial Participant collected pursuant to the Protocol (“Specimens”) as well as RNA, DNA, and protein sequence, restriction fragment length polymorphism (RFLP), and similar data collected pursuant to the Protocol (“Genetic Data”). Any use of Genetic Data and/or Specimens, whether such use occurs as part of or outside of the Trial will be in accordance with the Protocol, other written instruction, the signed informed consent form of Trial Participants, and Applicable Law. Sponsor grants Institution access to Specimens and Genetic Data only for purposes of the Trial and follow-up health care for Trial Participants. Institution and Investigator shall deliver all Specimens and Genetic Data to Sponsor or its respective designee in a timely manner throughout the performance of the Trial, as provided in the Protocol, in no event later than sixty
Sample 1

Related to Specimens and Genetic Data

  • Immunizations (except for those preventive immunizations for routine use in children, adolescents, and adults that have in effect a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention);

  • Customer Materials Subject to Section 4(a), all right, title and interest (including all Intellectual Property Rights) in and to the Customer Materials are owned by Customer or Customer’s suppliers.

  • Background Screening VENDOR shall comply with all requirements of Sections 1012.32 and 1012.465, Florida Statutes, and all of its personnel who (1) are to be permitted access to school grounds when students are present, (2) will have direct contact with students, or (3) have access or control of school funds, will successfully complete the background screening required by the referenced statutes and meet the standards established by the statutes. This background screening will be conducted by SBBC in advance of VENDOR or its personnel providing any services under the conditions described in the previous sentence. VENDOR shall bear the cost of acquiring the background screening required by Section 1012.32, Florida Statutes, and any fee imposed by the Florida Department of Law Enforcement to maintain the fingerprints provided with respect to VENDOR and its personnel. The parties agree that the failure of VENDOR to perform any of the duties described in this section shall constitute a material breach of this Agreement entitling SBBC to terminate immediately with no further responsibilities or duties to perform under this Agreement. VENDOR agrees to indemnify and hold harmless SBBC, its officers and employees from any liability in the form of physical or mental injury, death or property damage resulting from VENDOR’s failure to comply with the requirements of this section or with Sections 1012.32 and 1012.465, Florida Statutes.

  • Third Party Materials The Application may display, include, or make available third-party content (including data, information, applications, and other products, services, and/or materials) or provide links to third-party websites or services, including through third- party advertising ("Third-Party Materials"). You acknowledge and agree that Company is not responsible for Third-Party Materials, including their accuracy, completeness, timeliness, validity, copyright compliance, legality, decency, quality, or any other aspect thereof. Company does not assume and will not have any liability or responsibility to you or any other person or entity for any Third-Party Materials. Third-Party Materials and links thereto are provided solely as a convenience to you, and you access and use them entirely at your own risk and subject to such third parties' terms and conditions.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!